154 related articles for article (PubMed ID: 33411224)
21. Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure, and factor X deficiency.
Stone WJ; Latos DL; Lankford PG; Baker AS
South Med J; 1978 Jul; 71(7):764-7. PubMed ID: 96536
[TBL] [Abstract][Full Text] [Related]
22. Beta2-microglobulin and renal bone disease.
Wada T; Miyata T; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
[TBL] [Abstract][Full Text] [Related]
23. A case of light chain (AL) amyloidosis with heart failure, renal dysfunction, and heparin-induced thrombocytopenia successfully treated with peritoneal dialysis.
Nakayama S; Kinugasa S; Hirose T; Miyake Y; Ota K; Onzo-Toyama M; Oba-Yabana I; Nakamura H; Tani J; Yumura W; Mori T
CEN Case Rep; 2021 May; 10(2):214-219. PubMed ID: 33113095
[TBL] [Abstract][Full Text] [Related]
24. Retroperitoneal Hematoma Causing Peritoneal Dialysis Catheter Malfunction.
Smith AA; Fonseca AN; Naljayan MV; Paramesh AS
J La State Med Soc; 2016; 168(4):137-9. PubMed ID: 27598897
[TBL] [Abstract][Full Text] [Related]
25. Paraffin Immunofluorescence Increases Light-Chain Detection in Extra-Renal Light Chain Amyloidosis and Other Light-Chain-Associated Diseases.
Gibier JB; Perbet R; Lopez B; Colombat M; Dubois R; Humez S; Terriou L; Copin MC; Gnemmi V
Arch Pathol Lab Med; 2021 Mar; 145(3):352-358. PubMed ID: 32539437
[TBL] [Abstract][Full Text] [Related]
26. [Hemoperitoneum and endocarditis].
Sastre López A; Mascarós Ferrer V; Iñigo Vanrell V; Gascó Company JM
Nefrologia; 2008; 28(1):114-5. PubMed ID: 18336149
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Subdural Hematoma Risk between Hemodialysis and Peritoneal Dialysis Patients with ESRD.
Wang IK; Cheng YK; Lin CL; Peng CL; Chou CY; Chang CT; Yen TH; Huang CC; Sung FC; Hsu CY
Clin J Am Soc Nephrol; 2015 Jun; 10(6):994-1001. PubMed ID: 25825482
[TBL] [Abstract][Full Text] [Related]
28. Effects of AA amyloidosis on survival in peritoneal dialysis.
Koc Y; Basturk T; Unsal A; Sakaci T; Ahbap E; Sinangil A; Budak SK; Sevinc M; Kayalar AO; Doner B
Kidney Blood Press Res; 2012; 36(1):182-90. PubMed ID: 23147073
[TBL] [Abstract][Full Text] [Related]
29. Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review.
Greenberg A; Bernardini J; Piraino BM; Johnston JR; Perlmutter JA
Am J Kidney Dis; 1992 Mar; 19(3):252-6. PubMed ID: 1553970
[TBL] [Abstract][Full Text] [Related]
30. [Sclerosing encapsulating peritonitis after peritoneal dialysis].
Cestari AT; Conti ML; Prats JA; Sato Junior H; Abensur H
J Bras Nefrol; 2013; 35(1):65-8. PubMed ID: 23598754
[TBL] [Abstract][Full Text] [Related]
31. Combination Therapy with Peritoneal Dialysis and Hemodialysis from the Initiation of Renal Replacement Therapy Preserves Residual Renal Function and Serum Albumin.
Ueda A; Nagai K; Hirayama A; Saito C; Yamagata K
Adv Perit Dial; 2017 Jan; 33(2017):74-78. PubMed ID: 29668437
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of Urgent-Start Peritoneal Dialysis in Older Patients with End-Stage Renal Disease: A Single-Center Experience.
Jin H; Ni Z; Mou S; Lu R; Fang W; Huang J; Hu C; Zhang H; Yan H; Li Z; Yu Z
Perit Dial Int; 2018; 38(2):125-130. PubMed ID: 29162677
[TBL] [Abstract][Full Text] [Related]
33. Bilateral kidney infarction due to primary Al amyloidosis: a first case report.
Mihout F; Joseph L; Brocheriou I; Leblond V; Varnous S; Ronco P; Plaisier E
Medicine (Baltimore); 2015 May; 94(17):e777. PubMed ID: 25929920
[TBL] [Abstract][Full Text] [Related]
34. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
35. [Amyloidosis and renal failure].
Musini S; Savazzi GM
Recenti Prog Med; 1999 Oct; 90(10):530-5. PubMed ID: 10592739
[TBL] [Abstract][Full Text] [Related]
36. Destructive Spondyloarthropathy in Patients on Long-Term Peritoneal Dialysis or Hemodialysis.
Hayami N; Hoshino J; Suwabe T; Sumida K; Mise K; Hamanoue S; Sawa N; Kitajima I; Hirota Y; Oohashi K; Fujii T; Okuda I; Takaichi K; Ubara Y
Ther Apher Dial; 2015 Aug; 19(4):393-8. PubMed ID: 25851461
[TBL] [Abstract][Full Text] [Related]
37. Peritoneal Dialysis as an Option for Unplanned Dialysis Initiation in Patients with End-Stage Renal Disease and Diabetes Mellitus.
Jin H; Ni Z; Che X; Gu L; Zhu M; Yuan J; Huang J; Gu A; Jin Y; Yan H; Wang Q; Yu Z; Zhou W; Fang W
Blood Purif; 2019; 47(1-3):52-57. PubMed ID: 30223256
[TBL] [Abstract][Full Text] [Related]
38. [Renal amyloidosis].
Cuchard P; Cuchard R; Rotman S; Burnier M; Gauthier T
Rev Med Suisse; 2012 Feb; 8(330):446-51. PubMed ID: 22452129
[TBL] [Abstract][Full Text] [Related]
39. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
Schaeffer J; Floege J; Ehlerding G; Koch KM
Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
[TBL] [Abstract][Full Text] [Related]
40. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
